BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsNHS National Framework for Antiretroviral Medications (Etravirine, Raltegravir, Ritonavir)
    Closed contract

    NHS National Framework for Antiretroviral Medications (Etravirine, Raltegravir, Ritonavir)

    Contract value
    £5.4m
    Closed 1 Jul 2026

    NHS is establishing a 12-month national framework agreement for supply of three antiretroviral tablets across two regional lots, with optional extension up to 24 months.

    🇬🇧United Kingdom· EnglandPublished 3 Jun 2026· 2 months agoviaFind a Tender
    Contract value
    £5.4m
    Closed 1 Jul 2026
    Tender deadline passed on 1 Jul 2026.

    Decision brief

    4 fields
    • Contract value
      est.£5,400,000
      Pounds sterling
    • Tender closed
      1 Jul 2026
      1 months ago
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇧United Kingdom
      England

    Lifecycle

    Closed

    Tender closed on 1 Jul 2026. Awaiting award.

    3 Jun 2026Today1 Jul 2026

    Brief

    The NHS is seeking suppliers for a national framework agreement to provide three antiretroviral medications: Etravirine 200mg tablets, Raltegravir 400mg tablets, and Ritonavir 100mg tablets. The framework is divided into two lots covering different NHS regions: Lot 1 covers DNE, LNW, and SOFE regions, while Lot 2 covers DNW and MAE regions. The initial framework period runs from 1 November 2026 to 31 October 2027 (12 months), with an option to extend for up to 24 additional months at the discretion of the NHS England Authority. Suppliers should contact NHS Medicines Value & Access, NHS England (Medicines Procurement and Supply Chain) for further details. Offer reference: CM/TNS/26/5745.

    Track record

    6 awards · 6 winners
    Open panel

    Mostly framework call-offs rather than head-to-head competition.

    In healthcare medical, NHS ENGLAND has awarded 6 contracts to 6 suppliers.

    Who wins here
    1. Amgen Ltd1× · 17%
    2. IMMUNOIVD AB1× · 17%
    3. ASPIRE PHARMA LIMITED1× · 17%
    4. AVENTIS PHARMA LIMITED t-a Sanofi1× · 17%
    5. ImmunoIVD1× · 17%
    6. Zentiva Pharma UK Ltd1× · 17%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from NHS ENGLAND

    4 listingsView all →
    OpenHealthcare & Medical🇬🇧United Kingdom

    Hyperbaric Oxygen Therapy Services Contract - North West and North East/Yorkshire Regions

    NHS England is seeking to award hyperbaric oxygen therapy service contracts for two regions with a combined value of £13.9 million, starting April 2026 for up to 6.5 years.

    NHS ENGLAND
    Published 21 Aug 2026
    AwardedEducation & Training🇬🇧United Kingdom

    Master's Degree in Public Health at University of Birmingham

    Two-year Master's degree in Public Health delivered by the University of Birmingham under Light Touch Regime procurement.

    £248,250NHS ENGLAND
    Published 21 Aug 2026
    AwardedEducation & Training🇬🇧United Kingdom

    FPH Diplomate Examination Preparation Support

    NHS England-funded preparation support service for Faculty of Public Health Diplomate examination candidates delivered by the University of Birmingham.

    £54,400NHS ENGLAND
    Published 20 Aug 2026
    AwardedEducation & Training🇬🇧United Kingdom

    Support for Young People Applying to Medical and Health Professions 2026/27

    One-year programme providing mentoring and academic support to help disadvantaged young people prepare for and apply to medical, dental, and other health undergraduate degree courses.

    £345,000NHS ENGLAND
    Published 20 Aug 2026

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Early Cancer Diagnostic Technologies Development Programme

    Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Validation of Early Cancer Diagnostic Technologies

    Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.

    est.£25,400,000
    Published 1 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Doxycycline 10-Pack Supply - Market Engagement 2027

    UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 21 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Patient Diagnostic and Monitoring Electrodes - Market Engagement Survey

    Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.

    Business Services Organisation Procurement and Logistics
    Published 21 Aug 2026
    Take action
    View on sourceFind a Tender

    Original closed notice on the publisher's site

    Publisher
    UK Cabinet Office
    Licence
    OGL v3.0
    Source
    find-tender.service.gov.uk
    Record ID
    ocds-h6vhtk-0668c0
    NE
    Buyer
    NHS ENGLAND
    Sector
    Healthcare & Medical